Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlle... von Fuchs, Charles S, Dr Prof, Tomasek, Jiri, MD, Yong, Cho Jae, Prof, Dumitru, Filip, MD, Passalacqua, Rodolfo, MD, Goswami, Chanchal, Prof, Safran, Howard, Prof, dos Santos, Lucas Vieira, MD, Aprile, Giuseppe, MD, Ferry, David R, Prof, Melichar, Bohuslav, Prof, Tehfe, Mustapha, MD, Topuzov, Eldar, Prof, Zalcberg, John Raymond, Prof, Chau, Ian, MD, Campbell, William, Prof, Sivanandan, Choondal, MD, Pikiel, Joanna, MD, Koshiji, Minori, MD, Hsu, Yanzhi, PhD, Liepa, Astra M, PharmD, Gao, Ling, PhD, Schwartz, Jonathan D, MD, Tabernero, Josep, MD

Volltext

Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial von Dutton, Susan J, MSc, Ferry, David R, Prof, Blazeby, Jane M, Prof, Abbas, Haider, MRCP, Dahle-Smith, Asa, MBChB, Mansoor, Wasat, PhD, Thompson, Joyce, FRCP, Harrison, Mark, PhD, Chatterjee, Anirban, FRCR, Falk, Stephen, MD, Garcia-Alonso, Angel, MD, Fyfe, David W, MD, Hubner, Richard A, PhD, Gamble, Tina, Peachey, Lynnda, BSc, Davoudianfar, Mina, BA, Pearson, Sarah R, BSc, Julier, Patrick, MSc, Jankowski, Janusz, Prof, Kerr, Rachel, MD, Petty, Russell D, MRCP

Volltext

Gefitinib and EGFR Gene Copy Number Aberrations in Esophageal Cancer von Petty, Russell D, Dahle-Smith, Asa, Stevenson, David A J, Osborne, Aileen, Massie, Doreen, Clark, Caroline, Murray, Graeme I, Dutton, Susan J, Roberts, Corran, Chong, Irene Y, Mansoor, Wasat, Thompson, Joyce, Harrison, Mark, Chatterjee, Anirban, Falk, Stephen J, Elyan, Sean, Garcia-Alonso, Angel, Fyfe, David Walter, Wadsley, Jonathan, Chau, Ian, Ferry, David R, Miedzybrodzka, Zosia

Volltext

Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial von Seymour, Matthew T, Prof, Maughan, Timothy S, Prof, Ledermann, Jonathan A, Prof, Topham, Clare, MD, James, Roger, Prof, Gwyther, Stephen J, MBBS, Smith, David B, MD, Shepherd, Stephen, MD, Maraveyas, Anthony, PhD, Ferry, David R, Prof, Meade, Angela M, PhD, Thompson, Lindsay, MSc, Griffiths, Gareth O, MSc, Parmar, Mahesh KB, Prof, Stephens, Richard J

Volltext

Simple ammonium salts acting on sigma-1 receptors yield potential treatments for cancer and depression von Brimson, James M., Akula, Kiran K., Abbas, Haider, Ferry, David R., Kulkarni, Shrinivas K., Russell, Steven T., Tisdale, Michael J., Tencomnao, Tewin, Safrany, Stephen T.

Volltext

A Phase II Study of Gefitinib Monotherapy in Advanced Esophageal Adenocarcinoma: Evidence of Gene Expression, Cellular, and Clinical Response von FERRY, David R, ANDERSON, Mark, BEDDARD, Kate, TOMLINSON, Simon, ATHERFOLD, Paul, OBSZYNSKA, Jolanta, HARRISON, Rebecca, JANKOWSKI, Janusz

Volltext

Hazards of Using Masking Protocols When Performing Ligand Binding Assays: Lessons From the Sigma-1 and Sigma-2 Receptors von Abbas, Haider, Borde, Preeti, Willars, Gary B., Ferry, David R., Safrany, Stephen T.

Volltext

Hepatic drug targeting: Phase I evaluation of polymer-bound Doxorubicin von SEYMOUR, Leonard W, FERRY, David R, ANDERSON, David, HESSLEWOOD, Stuart, JULYAN, Peter J, POYNER, Richard, DORAN, Jayne, YOUNG, Annie M, BURTLES, Sally, KERR, David J

Volltext

Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup an... von Tabernero, Josep, Van Cutsem, Eric, Lakomý, Radek, Prausová, Jana, Ruff, Paul, van Hazel, Guy A, Moiseyenko, Vladimir M, Ferry, David R, McKendrick, Joseph J, Soussan-Lazard, Karen, Chevalier, Soazig, Allegra, Carmen J

Volltext

Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer von SEYMOUR, Leonard W, FERRY, David R, SCHATZLEIN, Andreas, JODRELL, Duncan, BISSETT, Donald, CALVERT, Hilary, LIND, Mike, ROBBINS, Adele, BURTLES, Sally, DUNCAN, Ruth, CASSIDY, James, KERR, David J, REA, Daniel, WHITLOCK, Maggie, POYNER, Richard, BOIVIN, Christopher, HESSLEWOOD, Stuart, TWELVES, Christopher, BLACKIE, Robert

Volltext

Exposure–response relationship for ramucirumab from the randomized, double-blind, phase 3 REVEL trial (docetaxel versus docetaxel plus ramucirumab) in second-line treatment of meta... von Smit, Egbert F., Garon, Edward B., Reck, Martin, Cappuzzo, Federico, Bidoli, Paolo, Cohen, Roger B., Gao, Ling, O’Brien, Lisa M., Lee, Pablo, Zimmermann, Annamaria, Ferry, David R., Melemed, Allen S., Pérol, Maurice

Volltext

Hepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin von Seymour, L. W.

Volltext

The functional purification of P-glycoprotein is dependent on maintenance of a lipid–protein interface von Callaghan, Richard, Berridge, Georgina, Ferry, David R, Higgins, Christopher F

Volltext

Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy von Ruff, Paul, Ferry, David R, Lakomỳ, Radek, Prausová, Jana, Van Hazel, Guy A, Hoff, Paulo M, Cunningham, David, Arnold, Dirk, Schmoll, Hans J, Moiseyenko, Vladimir M, McKendrick, Joseph J, ten Tije, Albert J, Vishwanath, Raghu L, Bhargava, Pankaj, Chevalier, Soazig, Macarulla, Teresa, Van Cutsem, Eric

Volltext

A phase II open-label study of DHA-paclitaxel (Taxoprexin) by 2-h intravenous infusion in previously untreated patients with locally advanced or metastatic gastric or oesophageal a... von Jones, Robert J., Hawkins, Robert E., Eatock, Martin M., Ferry, David R., Eskens, Ferry A. L. M., Wilke, HansJochen, Evans, T. R. Jeffry

Volltext

Outcomes in Patients with Acute Non–Q-Wave Myocardial Infarction Randomly Assigned to an Invasive as Compared with a Conservative Management Strategy von Boden, William E, O'Rourke, Robert A, Crawford, Michael H, Blaustein, Alvin S, Deedwania, Prakash C, Zoble, Robert G, Wexler, Laura F, Kleiger, Robert E, Pepine, Carl J, Ferry, David R, Chow, Bruce K, Lavori, Philip W

Volltext

Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine von Julyan, Peter J, Seymour, Leonard W, Ferry, David R, Daryani, Sunil, Boivin, Christopher M, Doran, Jayne, David, Marilyn, Anderson, David, Christodoulou, Christos, Young, Annie M, Hesslewood, Stuart, Kerr, David J

Volltext

Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition von FERRY, D. R, SMITH, A, MALKHANDI, J, FYFE, D. W, DETAKATS, P. G, ANDERSON, D, BAKER, J, KERR, D. J

Volltext

Mitral A velocity wave transit time to the outflow tract as a measure of left ventricular diastolic stiffness. Hemodynamic correlations in patients with coronary artery disease von Pai, R G, Suzuki, M, Heywood, J T, Ferry, D R, Shah, P M

Volltext

Effects of prior bevacizumab (B) use on outcomes from the VELOUR study: A phase III study of aflibercept (Afl) and FOLFIRI in patients (pts) with metastatic colorectal cancer (mCRC... von Allegra, Carmen Joseph, Lakomy, Radek, Tabernero, Josep, Prausová, Jana, Ruff, Paul, Van Hazel, Guy, Moiseyenko, Vladimir Mikhailovich, Ferry, David R, McKendrick, Joseph J, Van Cutsem, Eric

Volltext